Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1176.0
(-1.26%)
ILA 1176.0
(-1.26%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.9 Million ILS | -78.07% |
| 2022 | 13.25 Million ILS | -6.3% |
| 2021 | 14.14 Million ILS | -32.39% |
| 2020 | 20.92 Million ILS | 81.45% |
| 2019 | 11.53 Million ILS | -18.92% |
| 2018 | 14.22 Million ILS | 22.64% |
| 2017 | 11.59 Million ILS | 55.36% |
| 2016 | 7.46 Million ILS | 567.62% |
| 2015 | 1.11 Million ILS | -78.91% |
| 2014 | 5.3 Million ILS | -70.75% |
| 2013 | 18.12 Million ILS | 39.02% |
| 2012 | 13.03 Million ILS | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.76 Million ILS | 4163.24% |
| 2024 Q2 | 17.61 Million ILS | 537.57% |
| 2023 Q2 | 1.69 Million ILS | -52.05% |
| 2023 Q1 | 3.52 Million ILS | 100.63% |
| 2023 Q4 | -68 Thousand ILS | 96.97% |
| 2023 FY | 2.9 Million ILS | -78.07% |
| 2023 Q3 | -2.24 Million ILS | -232.8% |
| 2022 Q3 | 3.31 Million ILS | 13.92% |
| 2022 FY | 13.25 Million ILS | -6.3% |
| 2022 Q1 | 4.44 Million ILS | -16.0% |
| 2022 Q2 | 2.91 Million ILS | -34.58% |
| 2022 Q4 | 1.75 Million ILS | -46.94% |
| 2021 Q1 | 3.98 Million ILS | -0.45% |
| 2021 Q4 | 5.29 Million ILS | 211.1% |
| 2021 Q3 | 1.7 Million ILS | -46.21% |
| 2021 FY | 14.14 Million ILS | -32.39% |
| 2021 Q2 | 3.16 Million ILS | -20.58% |
| 2020 Q2 | 4.13 Million ILS | -24.32% |
| 2020 Q1 | 5.46 Million ILS | 11042.86% |
| 2020 FY | 20.92 Million ILS | 81.45% |
| 2020 Q4 | 4 Million ILS | -45.38% |
| 2020 Q3 | 7.32 Million ILS | 77.32% |
| 2019 Q1 | 3.67 Million ILS | 87.87% |
| 2019 FY | 11.53 Million ILS | -18.92% |
| 2019 Q4 | 49 Thousand ILS | -98.99% |
| 2019 Q3 | 4.85 Million ILS | 73.75% |
| 2019 Q2 | 2.79 Million ILS | -23.84% |
| 2018 Q4 | 1.95 Million ILS | -34.82% |
| 2018 FY | 14.22 Million ILS | 22.64% |
| 2018 Q1 | 4.95 Million ILS | 38038.46% |
| 2018 Q2 | 4.31 Million ILS | -13.05% |
| 2018 Q3 | 2.99 Million ILS | -30.46% |
| 2017 FY | 11.59 Million ILS | 55.36% |
| 2017 Q1 | 2.15 Million ILS | 202.96% |
| 2017 Q2 | 5.8 Million ILS | 168.86% |
| 2017 Q3 | 3.62 Million ILS | -37.56% |
| 2017 Q4 | 13 Thousand ILS | -99.64% |
| 2016 Q2 | 3.59 Million ILS | 6.56% |
| 2016 FY | 7.46 Million ILS | 567.62% |
| 2016 Q1 | 3.37 Million ILS | 4.75% |
| 2016 Q4 | -2.09 Million ILS | -180.71% |
| 2016 Q3 | 2.59 Million ILS | -27.7% |
| 2015 FY | 1.11 Million ILS | -78.91% |
| 2015 Q4 | 3.21 Million ILS | -23.82% |
| 2015 Q3 | 4.22 Million ILS | 628.0% |
| 2015 Q2 | -800 Thousand ILS | -247.33% |
| 2015 Q1 | 543 Thousand ILS | 108.91% |
| 2014 Q2 | 2.06 Million ILS | -49.1% |
| 2014 Q4 | -6.09 Million ILS | -239.62% |
| 2014 FY | 5.3 Million ILS | -70.75% |
| 2014 Q3 | 4.36 Million ILS | 111.37% |
| 2014 Q1 | 4.05 Million ILS | 194.53% |
| 2013 FY | 18.12 Million ILS | 39.02% |
| 2013 Q2 | 2.03 Million ILS | 1729.6% |
| 2013 Q3 | 1.72 Million ILS | -15.37% |
| 2013 Q4 | -4.29 Million ILS | -349.07% |
| 2013 Q1 | -125 Thousand ILS | -104.13% |
| 2012 Q4 | 3.02 Million ILS | 17.41% |
| 2012 Q3 | 2.57 Million ILS | 0.0% |
| 2012 FY | 13.03 Million ILS | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cannabotech LTD | -16.62 Million ILA | 117.48% |